[1] Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol, 2020,73:202-209.
[2] Li J, Zou B, Yeo Y H, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol, 2019, 4: 389-398.
[3] Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol, 2015, 62: S47-S64.
[4] Sheka AC, Adeyi O, Thompson J, et al. Nonalcoholic steatohepatitis: a review. JAMA, 2020, 323:1175-1183.
[5] Yang BB, Chen YH, Zhang C, et al. Low vitamin D status is associated with advanced liver fibrosis in patients with nonalcoholic fatty liver disease. Endocrine, 2017, 55: 582-590.
[6] Gonzalez-Sanchez E, Firrincieli D, Housset C, et al. Expression patterns of nuclear receptors in parenchymal and non-parenchymal mouse liver cells and their modulation in cholestasis. Biochim Biophys Acta Mol Basis Dis, 2017, 1863:1699-1708.
[7] Zhou Y, Dong B, Kim KH, et al. Vitamin D receptor activation in liver macrophages protects against hepatic endoplasmic reticulum stress in mice. Hepatology, 2020, 71: 1453-1466.
[8] Lu W, Li X, Liu N, et al. Vitamin D alleviates liver fibrosis by inhibiting histidine-rich calcium binding protein (HRC). Chem Biol Interact, 2021, 334:109355.
[9] Dong B, Zhou Y, Wang W, et al. Vitamin D receptor activation in liver macrophages ameliorates hepatic inflammation, steatosis, and insulin resistance in mice. Hepatology, 2020, 71:1559-1574.
[10] Itagaki H, Shimizu K, Morikawa S, et al. Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice. Int J Clin Exp Pathol, 2013, 6: 2683-2696.
[11] 张阳, 李军祥, 王允亮. 胆汁酸代谢及其受体在非酒精性脂肪性肝病发生发展中的作用. 临床肝胆病杂志, 2020, 36:1374-1377.
[12] Meza-Meza MR, Ruiz-Ballesteros AI, de la Cruz-Mosso U. Functional effects of vitamin D: from nutrient to immunomodulator. Crit Rev Food Sci Nutr, 2020, 23:1-21.
[13] Ishizawa M, Akagi D, Makishima M. Lithocholic acid is a vitamin D receptor ligand that acts preferentially in the lleum. Int J Mol Sci, 2018, 19:1975.
[14] Han S, Chiang JY. Mechanism of vitamin D receptor inhibition of cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes. Drug Metab Dispos, 2009,37: 469-478.
[15] Qin X, Wang X. Role of vitamin D receptor in the regulation of?CYP3A?gene expression. Acta Pharm Sin B, 2019, 9:1087-1098.
[16] Cheng J, Fang ZZ, Kim JH, et al. Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice. J Lipid Res, 2014, 55: 455-465.
[17] Nehring JA, Zierold C, DeLuca HF. Lithocholic acid can carry out in vivo functions of vitamin D. Proc Natl Acad Sci U S A, 2007, 104: 10006-10009.
[18] Yao B, He J, Yin X, et al. The protective effect of lithocholic acid on the intestinal epithelial barrier is mediated by the vitamin D receptor via a SIRT1/Nrf2 and NF-κB dependent mechanism in Caco-2 cells. Toxicol Lett, 2019, 316: 109-118.
[19] Sun J. VDR/vitamin D receptor regulates autophagic activity through ATG16L1. Autophagy, 2016, 12: 1057-1058.
[20] Jin D, Wu S, Zhang YG, et al. Lack of vitamin D receptor causes dysbiosis and changes the functions of the murine intestinal microbiome. Clin Ther, 2015, 37: 996-1009.e7.
[21] Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J, 2005, 19: 1067-1077.
[22] 唐寒秋, 李晓涛, 闫雪,等. 1,25-二羟维生素D3通过调节NF-节素和TGF-素5-logy通路减轻小鼠非酒精型脂肪性肝炎和肝纤维化. 西北国防医学杂志, 2016, 37:497-500.
[23] Martínez-Sena T, Soluyanova P, Guzmán C, et al. The vitamin D receptor regulates glycerolipid and phospholipid metabolism in human hepatocytes. Biomolecules, 2020, 10: 493.
[24] Bozic M, Guzmán C, Benet M, et al. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis. J Hepatol, 2016, 65: 748-757.
[25] Zhang H, Shen Z, Lin Y, et al. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease. J Biol Chem, 2020, 295: 3891-3905. |
